3
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Enzymuria and Tubular Proteinuria in Diabetic Rats: A 12-Week Follow-Up Study

, &
Pages 41-47 | Published online: 07 Jul 2009

References

  • Deckert T, Parving H-H, Andersen A R, Christiansen J S, Oxen-Boll B, Svendsen PAa, Telmer S, Christy M, Lauritzen T, Thomsen O F, Kreiner S, Anderson J R, Binder C. Diabetic nephropathy: A clinical and morphometric study. Advances in Diabetes Epidemiology, E Eschwege. Excerpta Medica, Amsterdam 1982; 235–243
  • Andersen A R, Christiansen J S, Andersen J K, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemological study. Diabetologia 1983; 25: 493–501
  • Oakley W G, Pyke D A, Tattersall R B, Watkins PJ. Long-term diabetes: A clinical study of 92 patients after 40 years. Q J Med 1974; 43: 146–156
  • Mathiesen E R, Oxenboll B, Johansen PAa, Sevendsen P A, Deckert T. Incipient nephropathy in type I (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410
  • Viberti G C, Jarrett R J, Mahmud U, Hill R P, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432
  • Mogensen C E, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93
  • Shima K, Hirota M, Fukuda M, Tanaka A. Determination of urinary lysozyme for potential detection of tubular dysfunction in diabetic nephropathy. Clin Chem 1986; 32/10: 1818–1822
  • Miltényl M, Körner A, Tulassay T, Szabó A. Tubular dysfunction in type I diabetes mellitus. Arch Dis Child 1985; 60: 929–931
  • Mutti A. Detection of renal diseases in humans: developing markers and methods. Toxicol Lett 1989; 46: 177–191
  • Price RG. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982; 23: 99–134
  • Bernard A, Buchet J P, Roels H, Masson P, Lauwerys R. Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest 1979; 9: 11–22
  • Dierickx PJ. Urinary gamma-glutamyl transferase as an indicator of acute nephrotoxicity in rats. Arch Toxicol 1981; 47: 109–215
  • Jung K, Scholz D. An optimized assay of alanine aminopeptidase activity in urine. Clin Chem 1980; 26/9: 1251–1254
  • Leaback D H, Walker PG. Studies on glucosaminidase 4. The fluorometric assay of N-acetyl-β-glucosaminidase. Biochem J 1961; 78: 151–156
  • Bernard Lauwerys A.R. Comparison of turbidimetry with particle counting for the determination of human β2-microglobulin by latex immunoassay. Clin Chim Acta 1982; 119: 335–339
  • Evans J S, Gerritsen G C, Mann K M, Owen SP. Antitumor and hyperglycemic activity of streptozotocin (NSC-37917) and its co-factor, U-15,774. Cancer Chemother Rep 1965; 48: 1–6
  • Rakieten N, Rakieten M L, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963; 29: 91–98
  • Pitkin R M, Reynolds AW. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 1970; 19: 85
  • Sadoff L. Nephrotoxicity of streptozotocin (NSC-85998). Cancer Chemother Rep 1970; 54: 457–459
  • Weil R, Nozawa M, Koss M, Weber C, Reemtsma K, McIntosh R. The kidney in streptozotocin diabetic rats. Arch Pathol Lab Med 1976; 100: 37–49
  • Evan A P, Mang S A, Gattone V H, Connors B A, Aronoff G R, Luft FC. The effect of streptozotocin and streptozotocin-induced diabetes on the kidney. Renal Physiol 1984; 7: 78–89
  • Viau C, Bernard A, Lauwerys R. Determination of rat β2-microglobulin in urine and in serum. II. Application of its urinary measurement to selected nephrotoxicity models. J Appl Toxicol 1986; 6: 191–195
  • Karunanayake E H, Hearse D J, Mellows G. Streptozotocin: Its excretion and metabolism in the rat. Diabetologia 1976; 12: 483–488
  • Bauman JW, Jr. Proteinuria in long term streptozotocin diabetes in rats. Life Sciences. Pergamon Press Ltd. 1980; vol. 27: 2121–2124
  • Raash B, Baretton G, Siegers CP. Effect of diabetic state on the nephrotoxicity of cyclosporin A. Poster presentation at the Fourth International Nephrotoxicity Symposium. GuildfordEngland 1989
  • Mattenheimen H. Enzymes in Renal Diseases. Ann Clin Lab Sci 1977; 7: 422–432
  • Kuwahara M D, Lyons S A, Rosenblit P D, Metzger RP. Effect of streptozotocin diabetes on selected enzymatic activities in rat urine. Proc Soc Exp Biol Med 1976; 153: 305–308
  • Viau C, Wouters J R, Chouinard S. Inhibition of the renal re-absorption of rat β2-microglobulin by lysozyme in perfused rats. Contrib Nephrol 1990; 83: 88–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.